Shares of Henry Schein Inc. (NASDAQ:HSIC) dropped 1.4% during mid-day trading on Tuesday . The company traded as low as $160.18 and last traded at $160.23, with a volume of 242,580 shares changing hands. The stock had previously closed at $162.48.

HSIC has been the subject of a number of research analyst reports. Vetr upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $176.75 price target for the company in a research report on Monday, May 2nd. Barrington Research reiterated an “outperform” rating and set a $188.00 price target (up previously from $182.00) on shares of Henry Schein in a research report on Wednesday, May 4th. Zacks Investment Research upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $189.00 price target for the company in a research report on Wednesday, May 4th. Leerink Swann reiterated a “hold” rating on shares of Henry Schein in a research report on Thursday, May 5th. Finally, Credit Suisse Group AG reiterated a “hold” rating on shares of Henry Schein in a research report on Saturday, June 4th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company’s stock. Henry Schein has an average rating of “Hold” and a consensus target price of $155.37.

The firm’s 50 day moving average is $173.32 and its 200 day moving average is $170.95. The company has a market capitalization of $13.07 billion and a PE ratio of 27.08.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Thursday, August 4th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.63 by $0.01. During the same quarter in the previous year, the company earned $1.46 EPS. The company earned $2.87 billion during the quarter, compared to analysts’ expectations of $2.85 billion. The business’s quarterly revenue was up 9.3% compared to the same quarter last year. Analysts forecast that Henry Schein Inc. will post $6.57 EPS for the current fiscal year.

In other Henry Schein news, EVP Gerald A. Benjamin sold 9,991 shares of the company’s stock in a transaction dated Thursday, June 2nd. The stock was sold at an average price of $175.08, for a total value of $1,749,224.28. Following the completion of the sale, the executive vice president now owns 54,885 shares in the company, valued at $9,609,265.80. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Several hedge funds have added to or reduced their stakes in the company. Utah Retirement Systems boosted its stake in Henry Schein by 0.7% in the fourth quarter. Utah Retirement Systems now owns 15,125 shares of the company’s stock valued at $2,393,000 after buying an additional 100 shares in the last quarter. American International Group Inc. boosted its stake in Henry Schein by 2.3% in the fourth quarter. American International Group Inc. now owns 34,438 shares of the company’s stock valued at $5,447,000 after buying an additional 762 shares in the last quarter. Victory Capital Management Inc. boosted its stake in Henry Schein by 18.8% in the fourth quarter. Victory Capital Management Inc. now owns 8,124 shares of the company’s stock valued at $1,285,000 after buying an additional 1,284 shares in the last quarter. Principal Financial Group Inc. boosted its stake in Henry Schein by 3.2% in the fourth quarter. Principal Financial Group Inc. now owns 125,574 shares of the company’s stock valued at $19,864,000 after buying an additional 3,887 shares in the last quarter. Finally, KBC Group NV boosted its stake in Henry Schein by 594.3% in the fourth quarter. KBC Group NV now owns 35,692 shares of the company’s stock valued at $5,646,000 after buying an additional 30,551 shares in the last quarter.

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.